Skip to main content

IGM Biosciences, Inc.

IGMSDelisted Aug 14, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001496323

IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding IGM Biosciences, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of IGMS: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders109105−4
Shares18.0M16.3M−1.66M (−9.2%)
Value$1.38B$1.36B−$22.1M (−1.6%)

New holders (18)

Institutions that held IGM Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to IGMS in Q2 2021
InstitutionSharesValue% of portfolio
Bruce & Co., Inc.55,000$4.58M0.87%
Altium Capital Management LP42,473$3.53M0.82%
EcoR1 Capital, LLC38,030$3.16M0.12%
Eagle Bay Advisors LLC34,835$2.90M2.33%
Polar Capital Holdings Plc21,144$1.76M0.01%
Dimensional Fund Advisors LP7,853$653.0K0.00%
Los Angeles Capital Management LLC6,400$532.0K0.00%
Two Sigma Investments, LP5,000$416.0K0.00%
Invesco Ltd.4,164$346.0K0.00%
Blueshift Asset Management, LLC3,825$318.0K0.02%
AlphaCrest Capital Management LLC3,000$250.0K0.01%
Handelsbanken Fonder AB2,900$241.0K0.00%
HRT Financial LP2,762$229.0K0.00%
SEI Investments Co2,505$208.0K0.00%
Nisa Investment Advisors, LLC600$50.0K0.00%
Quantbot Technologies LP300$24.0K0.00%
TCI Wealth Advisors, Inc.31$3.00K0.00%
The PNC Financial Services Group, Inc.12$1.00K0.00%

Sold out (22)

Institutions that held IGM Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.